FIGS Klasa A FIGS, Inc. Class A Common Stock
NYSE · Textiles, Apparel & Luxury Goods · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026FIGS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
FIGS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O FIGS, Inc. Class A Common Stock Przegląd firmy z Wikipedii
Figs (stylized as FIGS) is an American clothing company based in Santa Monica, California. The company sells scrubs and other products for healthcare professionals. It was founded in 2013 by Heather Hasson and Trina Spear, who are co-CEOs.
History
FIGS was founded by Heather Hasson and Trina Spear in Los Angeles, California in 2013. Hasson had the business idea when she realized that, unlike companies such as Lululemon, Under Armour, and Nike, that make clothes for athletes, there were no companies making fitted uniforms for health care professionals. Spear worked on Wall Street at the time and helped Hasson develop the business idea.
Hasson and Spear started FIGS using only their personal savings. They designed an alternative to the common scrubs available. Initially, they sold their product out of the parking lots of hospitals, getting feedback from staff. In 2013, Hasson and Spear raised a $2 million seed round so that they would not run out of product. In 2014 and 2015, they raised an additional $3 million. In 2016, the Lululemon-backed venture capital fund, Campfire, led the Series A funding round, which raised $5 million.
In 2017, Thomas Tull, businessman and founder of Legendary Pictures, invested $65 million in the company and became majority owner of FIGS. Others who have invested include Will Smith, Irving Place Capital, former Lululemon CEO Christine Day, and Mohr Davidow Ventures.
The company headquarters are in Santa Monica, California. In December 2015, FIGS was selected to join the Endeavor network, a startup accelerator and mentorship program. As of 2018 the company had raised a total of $75 million in funding. FIGS was recognized as one of the fastest-growing companies in the United States by Inc. in 2018, with the company having a three-year growth of 9,948%.
In 2019 FIGS opened a pop-up shop in Los Angeles. It added face masks to its products during the coronavirus pandemic in 2020, and expanded sales to Australia and the United Kingdom. In 2020, revenue doubled to $263 million and profits were almost $50 million.
In May 2021 FIGS filed for an initial public offering for $3 billion. On May 27, 2021, it became the first company led by two female cofounders to trade on the New York Stock Exchange. Also for the first time, FIGS allowed retail investors early access to purchase shares before the official sale began on the NYSE.
In November 2022, a California jury rejected all claims made by a competitor as "not valid" in a lawsuit alleging FIGS had "false advertising and misleading business practices." The lawsuit was concluded after almost 4 years of litigation.
By 2023, non-scrub products, including lab coats, activewear, loungewear, footwear, and compression socks, accounted for approximately 20% of the company's revenue.
Operation
FIGS sells scrubs, other medical clothing and associated products, including scrub tops, scrub pants, underscrubs, lab coats, activewear, and loungewear. The scrubs are made with a proprietary material that is antimicrobial for odor resistance with four-way stretch and pockets.
All sales are online, via the company's website. FIGS predicted revenue of over $250 million in 2020, mostly through the sale of its upgraded scrubs. The company's warehouse is in City of Industry, California.
Charitable operations
FIGS also operates the Threads for Threads program, which donates sets of scrubs to countries with limited access to medical apparel. The program includes giving trips and results in the donations of scrubs around the world. By 2019 the initiative had donated over 500,000 sets of scrubs in over 35 countries.
In the COVID-19 pandemic in early 2020, FIGS donated 30,000 sets of scrubs to New York hospitals Bellevue and Mount Sinai, and sent 100 care packages to health care workers every week. It contracted the production of over one million N95 masks and also donated them to hospitals and medical professionals.
Marketing
In October 2020, FIGS released a promotional video featuring a female osteopathic physician in neon pink scrubs reading a book titled "Medical Terminology for Dummies" while holding it upside down. The camera then cut to a zoomed in view of a blank badge labeled with the letters "DO". The video was taken down after widespread criticism as sexist, particularly from female physicians and osteopathic physicians.
Hasson and Spear apologized for the video and said they planned to hire consultants to help with future videos to avoid repeating this mistake. FIGS later partnered with the American Osteopathic Association and pledged $100,000 to it.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | FIGS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 41.0średnia z 5 lat ≈5.8 | ≈5.8 | 18.9 | Zawyżona wycena |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | FIGS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 68.9%średnia z 5 lat ≈69.0% | ≈69.0% | 61.2% | Najwyższa półka | |
| Marża Operacyjna (TTM) | 9.6%średnia z 5 lat ≈4.6% | ≈4.6% | 6.9% | Najwyższa półka | |
| Marża EBITDA (TTM) | 11.1%średnia z 5 lat ≈5.3% | ≈5.3% | 8.0% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 10.8%średnia z 5 lat ≈5.5% | ≈5.5% | 7.7% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 8.7%średnia z 5 lat ≈2.4% | ≈2.4% | 5.8% | Najwyższa półka | |
| ROA (TTM) | 11.3%średnia z 5 lat ≈2.8% | ≈2.8% | 3.6% | Najwyższa półka | |
| ROE (TTM) | 14.8%średnia z 5 lat ≈3.6% | ≈3.6% | 9.3% | Zgodnie z | |
| ROIC | 6.3%średnia z 5 lat ≈2.8% | ≈2.8% | 7.1% | Zgodnie z |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | FIGS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 5.0średnia z 5 lat ≈5.1 | ≈5.1 | 2.1 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 1.0średnia z 5 lat ≈2.0 | ≈2.0 | 1.0 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | FIGS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 13.6%średnia z 5 lat ≈20.7% | ≈20.7% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 7.6%średnia z 5 lat ≈15.0% | ≈15.0% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 19.1% | · | · | · | |
| EPS YoY | 850.0%średnia z 5 lat ≈258.6% | ≈258.6% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 1159.2%średnia z 5 lat ≈359.4% | ≈359.4% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 20.0% | · | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -8.7% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 17.4% | · | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -7.2% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | FIGS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.2średnia z 5 lat ≈1.4 | ≈1.4 | 1.2 | Zgodnie z | |
| Inventory Turnover (Rotacja zapasów) | 1.7średnia z 5 lat ≈1.5 | ≈1.5 | 2.5 | Słaby | |
| Receivables Turnover (Rotacja należności) | 105.3średnia z 5 lat ≈100.8 | ≈100.8 | 9.0 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$1.9M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 6, 2026 | $0.11 | $0.07 | 59.7% |
| 31 marca 2026 | $0.03 | $0.02 | 96.1% | |
| 31 grudnia 2025 | $0.10 | $0.02 | 373.9% | |
| 30 września 2025 | $0.05 | $0.02 | 170.3% | |
| 30 czerwca 2025 | $0.04 | $0.02 | 106.2% | |
| 31 marca 2025 | $0.00 | $-0.00 | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $631M | $556M | $546M | $506M | $420M | $263M | $110M | |
| Cost of Revenue | $211M | $180M | $169M | $151M | $118M | $73M | $31M | |
| Gross Profit | $420M | $376M | $377M | $354M | $301M | $190M | $79M | |
| SG&A Expense | $143M | $143M | $141M | $121M | $150M | $42M | $22M | |
| Operating Expenses | $382M | $373M | $343M | $317M | $290M | $132M | $80M | |
| Operating Income | $38M | $2M | $34M | $38M | $11M | $58M | $-347.0K | |
| Other Non-op | $312.0K | $833.0K | $-13.0K | $-647.0K | $-885.0K | $0 | · | |
| Pretax Income | $47M | $14M | $41M | $39M | $10M | $58M | $112.0K | |
| Income Tax | $13M | $12M | $18M | $18M | $19M | $8M | $0 | |
| Net Income | $34M | $3M | $23M | $21M | $-10M | $50M | $112.0K | |
| EPS (Basic) | $0.21 | $0.02 | $0.13 | $0.13 | $-0.06 | $0.32 | $0.00 | |
| EPS (Diluted) | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 | $0.30 | $0.00 | |
| Shares (Basic) | 163,462,072 | 169,201,983 | 168,065,721 | 165,268,185 | 159,177,713 | 153,327,308 | 153,052,983 | |
| Shares (Diluted) | 179,486,886 | 180,102,840 | 182,412,965 | 187,547,474 | 159,177,713 | 163,331,348 | 153,624,013 | |
| EBITDA | $47M | $9M | $37M | $40M | $12M | · | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $82M | $86M | $144M | $160M | $195M | $58M | · | |
| Receivables | $5M | $7M | $7M | $6M | $2M | $6M | · | |
| Inventory | $128M | $116M | $119M | $178M | $86M | $50M | · | |
| Prepaid Expense | $12M | $13M | $12M | $12M | $7M | $7M | · | |
| Current Assets | $447M | $383M | $386M | $356M | $293M | $120M | · | |
| PP&E (Net) | $34M | $35M | $25M | $11M | $8M | $7M | · | |
| PP&E (Gross) | $56M | $48M | $33M | $16M | $10M | $8M | · | |
| Accum. Depreciation | $22M | $13M | $8M | $5M | $3M | $1M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $1M | $560.0K | $506.0K | · | |
| Total Assets | $580M | $510M | $473M | $395M | $312M | $134M | · | |
| Accounts Payable | $18M | $9M | $15M | $21M | $15M | $12M | · | |
| Accrued Liabilities | $21M | $42M | $8M | $26M | $25M | $7M | · | |
| Current Liabilities | $91M | $90M | $57M | $71M | $62M | $33M | · | |
| Capital Leases | $52M | $42M | $39M | $16M | $0 | · | · | |
| Other Non-current Liabilities | $182.0K | $83.0K | $183.0K | $176.0K | $243.0K | $0 | · | |
| Total Liabilities | $143M | $133M | $96M | $87M | $66M | $36M | · | |
| Common Stock | · | · | · | · | · | $15.0K | · | |
| Retained Earnings | $99M | $64M | $62M | $39M | $18M | $27M | · | |
| AOCI | $196.0K | $21.0K | $5.0K | $0 | · | · | · | |
| Stockholders' Equity | $437M | $377M | $377M | $308M | $246M | $98M | $39M | |
| Liabilities + Equity | $580M | $510M | $473M | $395M | $312M | $134M | · | |
| Shares Outstanding | · | · | · | · | 0 | 154,444,851 | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $3M | $2M | $1M | $946.0K | $500.0K | |
| Stock-based Comp | $27M | $43M | $46M | $37M | $81M | $9M | $179.0K | |
| Deferred Tax | $-544.0K | $7M | $-7M | $-732.0K | $-4M | $-7M | $0 | |
| Other Non-cash | $-8M | $22M | $37M | $-95M | $-3M | · | · | |
| Operating Cash Flow | $61M | $81M | $101M | $-35M | $66M | $22M | $7M | |
| CapEx | $8M | $17M | $16M | $5M | $3M | $2M | $5M | |
| Investing Cash Flow | $-64M | $-95M | $-117M | $-6M | $-3M | $-2M | $-5M | |
| Stock Issued | $0 | $250.0K | $0 | $0 | · | · | · | |
| Stock Repurchased | $3M | $45M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-3M | $-45M | · | · | · | · | · | |
| Financing Cash Flow | $-969.0K | $-45M | $670.0K | $4M | $76M | $294.0K | $14M | |
| Net Change in Cash | $-4M | $-59M | $-16M | $-38M | $139M | $20M | $16M | |
| Taxes Paid | $8M | $13M | $21M | $12M | $15M | $18M | $0 | |
| Free Cash Flow | $53M | $64M | $85M | $-41M | $64M | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% | · | · | |
| Operating Margin | 6.0% | 0.41% | 6.2% | 7.4% | 2.6% | · | · | |
| Net Margin | 5.4% | 0.49% | 4.2% | 4.2% | -2.3% | · | · | |
| Pretax Margin | 7.5% | 2.6% | 7.5% | 7.7% | 2.4% | · | · | |
| EBITDA Margin | 7.5% | 1.6% | 6.8% | 7.8% | 2.9% | · | · | |
| ROA | 6.3% | 0.55% | 5.2% | 6.0% | -4.3% | · | · | |
| ROE | 8.2% | 0.70% | 6.2% | 7.1% | -4.1% | · | · | |
| ROIC | 6.3% | 0.11% | 5.0% | 6.7% | -4.3% | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 4.2 | 6.7 | 5.0 | 4.7 | · | · | |
| Quick Ratio | 1.0 | 1.0 | 2.6 | 2.3 | 3.2 | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.3 | 1.4 | 1.9 | · | · | |
| Inventory Turnover | 1.7 | 1.5 | 1.1 | 1.1 | 1.7 | · | · | |
| Receivables Turnover | 105.3 | 84.3 | 85.0 | 127.4 | 102.1 | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.52 | $3.08 | $2.99 | $2.70 | $2.64 | · | · | |
| Cash Flow / Share | $0.34 | $0.45 | $0.55 | $-0.19 | $0.42 | · | · | |
| EPS (TTM) | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 1.8% | 7.9% | 20.5% | 59.5% | · | · | |
| Revenue CAGR 3Y | 7.6% | 9.8% | 27.5% | · | · | · | · | |
| Revenue CAGR 5Y | 19.1% | · | · | · | · | · | · | |
| EPS YoY | 850.0% | -83.3% | 9.1% | · | · | · | · | |
| EPS CAGR 3Y | 20.0% | · | -26.3% | · | · | · | · | |
| EPS CAGR 5Y | -8.7% | · | · | · | · | · | · | |
| Net Income YoY | 1159.2% | -88.0% | 6.9% | · | · | · | · | |
| Net Income CAGR 3Y | 17.4% | · | -23.1% | · | · | · | · | |
| Net Income CAGR 5Y | -7.2% | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $631M | $556M | $546M | $506M | $420M | · | · | |
| Net Income TTM | $34M | $3M | $23M | $21M | $-10M | · | · | |
| Market Cap | · | · | · | · | $0 | · | · | |
| P/E | 59.8 | 309.5 | 57.9 | 61.2 | -459.3 | · | · | |
| P/S | · | · | · | · | 0.0 | · | · | |
| P / Tangible Book | · | · | · | · | 0.0 | · | · | |
| P / Cash Flow | · | · | · | · | 0.0 | · | · | |
| P / FCF | · | · | · | · | 0.0 | · | · | |
| Earnings Yield | 1.7% | 0.32% | 1.7% | 1.6% | -0.22% | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $197M | $160M | $202M | $152M | $153M | $125M | $152M | $140M | $144M | $119M | $145M | $142M | $138M | $120M | $145M | $129M | |
| Cost of Revenue | $49M | $52M | $75M | $46M | $50M | $40M | $50M | $46M | $47M | $37M | $47M | $45M | $42M | $35M | $46M | $38M | |
| Gross Profit | $148M | $108M | $127M | $106M | $102M | $84M | $102M | $94M | $97M | $82M | $98M | $97M | $96M | $86M | $99M | $91M | |
| SG&A Expense | $40M | $38M | $37M | $37M | $35M | $34M | $36M | $36M | $36M | $36M | $35M | $36M | $35M | $34M | $37M | $28M | |
| Operating Expenses | $113M | $104M | $108M | $96M | $92M | $85M | $93M | $103M | $96M | $82M | $84M | $87M | $89M | $82M | $96M | $80M | |
| Operating Income | $35M | $4M | $19M | $10M | $10M | $-211.0K | $9M | $-9M | $2M | $443.0K | $14M | $10M | $7M | $3M | $3M | $11M | |
| Other Non-op | $-526.0K | $-277.0K | $307.0K | $9.0K | $-3.0K | $-1.0K | $841.0K | $2.0K | $0 | $-10.0K | $-2.0K | $-6.0K | $-4.0K | $-1.0K | $-647.0K | $1.0K | |
| Pretax Income | $37M | $6M | $21M | $12M | $12M | $2M | $12M | $-6M | $4M | $3M | $17M | $12M | $8M | $4M | $4M | $12M | |
| Income Tax | $9M | $157.0K | $3M | $3M | $5M | $2M | $10M | $-4M | $3M | $2M | $7M | $6M | $4M | $2M | $247.0K | $8M | |
| Net Income | $28M | $6M | $19M | $9M | $7M | $-102.0K | $2M | $-2M | $1M | $1M | $10M | $6M | $5M | $2M | $3M | $4M | |
| EPS (Basic) | $0.17 | $0.04 | $0.12 | $0.05 | $0.04 | $0.00 | $0.01 | $-0.01 | $0.01 | $0.01 | $0.05 | $0.04 | $0.03 | $0.01 | $0.03 | $0.02 | |
| EPS (Diluted) | $0.15 | $0.03 | $0.10 | $0.05 | $0.04 | $0.00 | $0.01 | $-0.01 | $0.01 | $0.01 | $0.06 | $0.03 | $0.02 | $0.01 | $0.01 | $0.02 | |
| Shares (Basic) | 166,467,633 | 166,460,085 | · | 163,665,566 | 162,683,329 | 162,465,988 | · | 170,168,732 | 170,393,480 | 169,923,479 | · | 168,668,844 | 167,423,656 | 166,773,335 | · | 165,543,067 | |
| Shares (Diluted) | 195,139,642 | 196,090,295 | · | 180,875,933 | 172,929,960 | 162,465,988 | · | 170,168,732 | 179,688,524 | 180,701,844 | · | 181,429,745 | 183,332,560 | 182,853,746 | · | 186,991,769 | |
| EBITDA | $35M | $8M | · | $10M | $10M | $2M | · | $-9M | $2M | $1M | · | $10M | $7M | $4M | · | $11M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $109M | $74M | $82M | $46M | $51M | $90M | $86M | $124M | $132M | $155M | · | $183M | $147M | $156M | · | $156M | |
| Receivables | $7M | $4M | $5M | $11M | $8M | $5M | $7M | $9M | $12M | $5M | · | $6M | $6M | $3M | · | $3M | |
| Inventory | $120M | $139M | $128M | $151M | $136M | $132M | $116M | $123M | $119M | $130M | · | $143M | $168M | $180M | · | $168M | |
| Prepaid Expense | $14M | $11M | $12M | $13M | $10M | $10M | $13M | $19M | $17M | $11M | · | $13M | $10M | $10M | · | $14M | |
| Current Assets | $453M | $432M | $447M | $418M | $394M | $400M | $383M | $434M | $417M | $406M | · | $395M | $369M | $350M | · | $346M | |
| PP&E (Net) | $33M | $33M | $34M | $34M | $33M | $34M | $35M | $35M | $35M | $28M | · | $16M | $11M | $11M | · | $11M | |
| PP&E (Gross) | $61M | $58M | $56M | $53M | $50M | $49M | $48M | $46M | $45M | $37M | · | $23M | $18M | $17M | · | $15M | |
| Accum. Depreciation | $28M | $25M | $22M | $19M | $17M | $15M | $13M | $11M | $10M | $9M | · | $7M | $6M | $5M | · | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $583M | $563M | $580M | $545M | $517M | $522M | $510M | $542M | $526M | $511M | · | $442M | $411M | $388M | · | $386M | |
| Accounts Payable | $9M | $8M | $18M | $5M | $19M | $11M | $9M | $27M | $20M | $22M | · | $15M | $12M | $9M | · | $21M | |
| Accrued Liabilities | $40M | $36M | $21M | $34M | $22M | $54M | $42M | $29M | $22M | $17M | · | $16M | $18M | $21M | · | $32M | |
| Current Liabilities | $91M | $80M | $91M | $87M | $78M | $101M | $90M | $95M | $77M | $72M | · | $70M | $57M | $53M | · | $76M | |
| Capital Leases | $49M | $52M | $52M | $45M | $42M | $40M | $42M | $44M | $48M | $49M | · | $16M | $17M | $15M | · | $17M | |
| Other Non-current Liabilities | $264.0K | $263.0K | $182.0K | $83.0K | $83.0K | $83.0K | $83.0K | $183.0K | $183.0K | $183.0K | · | $176.0K | $176.0K | $176.0K | · | $215.0K | |
| Total Liabilities | $140M | $133M | $143M | $131M | $121M | $141M | $133M | $139M | $124M | $121M | · | $87M | $74M | $68M | · | $93M | |
| Retained Earnings | $133M | $105M | $99M | $80M | $71M | $64M | $64M | $63M | $64M | $63M | · | $52M | $46M | $41M | · | $36M | |
| AOCI | $-240.0K | $-103.0K | $196.0K | $162.0K | $70.0K | $-24.0K | $21.0K | $221.0K | $-47.0K | $-26.0K | · | $-4.0K | $-8.0K | · | · | · | |
| Stockholders' Equity | $442M | $431M | $437M | $413M | $397M | $382M | $377M | $404M | $402M | $390M | $377M | $355M | $337M | $320M | $308M | $292M | |
| Liabilities + Equity | $583M | $563M | $580M | $545M | $517M | $522M | $510M | $542M | $526M | $511M | · | $442M | $411M | $388M | · | $386M |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $1M | $850.0K | $814.0K | $756.0K | $713.0K | $659.0K | $637.0K | $479.0K | |
| Stock-based Comp | $7M | $5M | $5M | $7M | $8M | $7M | $10M | $11M | $10M | $12M | $11M | $12M | $12M | $11M | $11M | $9M | |
| Deferred Tax | $6.0K | $6.0K | $911.0K | $-2M | $-893.0K | $995.0K | $6M | $-2M | $2M | $251.0K | $-5M | $-857.0K | $-544.0K | $-440.0K | $244.0K | $-661.0K | |
| Other Non-cash | · | $-18M | · | · | · | $-896.0K | · | · | · | $-3M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $47M | $-3M | $61M | $3M | $-12M | $9M | $30M | $23M | $17M | $12M | $20M | $54M | $29M | $-3M | $5M | $-13M | |
| CapEx | $3M | $2M | $3M | $3M | $1M | $1M | $3M | $4M | $9M | $496.0K | $7M | $8M | $841.0K | $772.0K | $1M | $3M | |
| Investing Cash Flow | $11M | $14M | $-26M | $-9M | $-27M | $-2M | $-31M | $-23M | $-40M | $-474.0K | $-59M | $-18M | $-39M | $-772.0K | $-1M | $-3M | |
| Stock Repurchased | $24M | $9M | $0 | $0 | $0 | $3M | $38M | $7M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-9M | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-23M | $-18M | $401.0K | $1M | $185.0K | $-3M | $-38M | $-7M | $254.0K | $10.0K | $153.0K | $126.0K | $636.0K | $-245.0K | $733.0K | $1M | |
| Net Change in Cash | $34M | $-8M | $36M | $-4M | $-39M | $4M | $-38M | $-8M | $-24M | $11M | $-39M | $36M | $-9M | $-4M | $4M | $-15M | |
| Free Cash Flow | · | $-6M | · | · | · | $8M | · | · | · | $11M | · | · | · | $-4M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.2% | 67.7% | · | 69.9% | 67.0% | 67.6% | · | 67.1% | 67.4% | 68.8% | · | 68.4% | 69.5% | 71.3% | · | 70.6% | |
| Operating Margin | 17.9% | 2.8% | · | 6.3% | 6.5% | -0.17% | · | -6.2% | 1.1% | 0.37% | · | 7.0% | 4.8% | 2.7% | · | 8.7% | |
| Net Margin | 14.4% | 3.9% | · | 5.8% | 4.7% | -0.08% | · | -1.2% | 0.76% | 1.2% | · | 4.3% | 3.3% | 1.6% | · | 3.1% | |
| Pretax Margin | 18.8% | 4.0% | · | 7.9% | 7.9% | 1.5% | · | -4.1% | 3.0% | 2.8% | · | 8.3% | 5.9% | 3.6% | · | 9.2% | |
| EBITDA Margin | 17.9% | 4.9% | · | 6.3% | 6.5% | 1.4% | · | -6.2% | 1.1% | 1.1% | · | 7.0% | 4.8% | 3.3% | · | 8.7% | |
| ROA | 5.2% | 1.2% | · | 1.6% | 1.4% | -0.02% | · | -0.35% | 0.23% | 0.32% | · | 1.5% | 1.2% | 0.52% | · | 1.2% | |
| ROE | 6.8% | 1.6% | · | 2.1% | 1.8% | -0.03% | · | -0.45% | 0.30% | 0.40% | · | 1.9% | 1.5% | 0.65% | · | 1.6% | |
| ROIC | 6.1% | 1.0% | · | 1.7% | 1.5% | 0.00% | · | -0.64% | 0.10% | 0.05% | · | 1.5% | 1.1% | 0.45% | · | 1.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.4 | · | 4.8 | 5.0 | 4.0 | · | 4.6 | 5.4 | 5.6 | · | 5.6 | 6.5 | 6.6 | · | 4.5 | |
| Quick Ratio | 1.3 | 1.0 | · | 0.7 | 0.8 | 0.9 | · | 1.4 | 1.9 | 2.2 | · | 2.7 | 2.7 | 3.0 | · | 2.1 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.4 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 26.8 | 34.3 | · | 15.2 | 15.6 | 24.3 | · | 19.4 | 16.7 | 29.5 | · | 34.0 | 27.8 | 39.9 | · | 34.3 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $1.01 | $0.82 | · | $0.84 | $0.88 | $0.77 | · | $0.82 | $0.80 | $0.66 | · | $0.78 | $0.75 | $0.66 | · | $0.69 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $0.06 | · | · | · | $0.06 | · | · | · | $-0.02 | · | · | |
| EPS (TTM) | $0.33 | $0.22 | · | $0.10 | $0.04 | $0.01 | · | $0.07 | $0.11 | $0.12 | · | $0.07 | $0.06 | $0.07 | · | $0.20 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $710M | $666M | · | $581M | $570M | $561M | · | $549M | $551M | $545M | · | $546M | $532M | $516M | · | $490M | |
| Net Income TTM | $62M | $41M | · | $18M | $7M | $1M | · | $11M | $19M | $22M | · | $16M | $14M | $14M | · | $30M | |
| P/E | 31.0 | 67.1 | · | 66.9 | 141.0 | 459.0 | · | 97.7 | 48.5 | 41.5 | · | 84.3 | 137.8 | 88.4 | · | 41.2 | |
| Earnings Yield | 3.2% | 1.5% | · | 1.5% | 0.71% | 0.22% | · | 1.0% | 2.1% | 2.4% | · | 1.2% | 0.73% | 1.1% | · | 2.4% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $631M | $556M | $546M | $506M | $420M |
| Marża Brutto % | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% |
| Marża Operacyjna % | 6.0% | 0.41% | 6.2% | 7.4% | 2.6% |
| Zysk netto | $34M | $3M | $23M | $21M | $-10M |
| Rozwodniony EPS | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 4.9 | 4.2 | 6.7 | 5.0 | 4.7 |
| Wskaźnik Szybkości | 1.0 | 1.0 | 2.6 | 2.3 | 3.2 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $53M | $64M | $85M | $-41M | $64M |
Właściciele instytucjonalni (13F) 261 emitentów · $1.7B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 48 (-16 vs poprzedni kw.) | 44 (+24 vs poprzedni kw.) | 91 (+6 vs poprzedni kw.) | 73 (+8 vs poprzedni kw.) | +7.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BAMCO INC /NY/ | $613 385 163 | 59 959 449 | 35,59% | Akcje |
| VANGUARD GROUP INC | $109 164 158 | 9 609 521 | 6,33% | Akcje |
| BlackRock, Inc. | $87 395 229 | 8 543 033 | 5,07% | Akcje |
| Driehaus Capital Management LLC | $52 799 465 | 5 161 238 | 3,06% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $47 786 110 | 4 671 174 | 2,77% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $44 938 896 | 4 392 854 | 2,61% | Akcje |
| MARSHALL WACE, LLP | $44 354 193 | 4 335 698 | 2,57% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $38 250 727 | 3 739 074 | 2,22% | Akcje |
| GOLDMAN SACHS GROUP INC | $37 747 165 | 3 689 850 | 2,19% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $37 264 048 | 3 641 706 | 2,16% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $36 514 827 | 3 568 384 | 2,12% | Akcje |
| Divisadero Street Capital Management, LP | $32 644 196 | 3 191 026 | 1,89% | Akcje |
| STATE STREET CORP | $27 017 614 | 2 641 018 | 1,57% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $24 874 429 | 2 431 518 | 1,44% | Akcje |
| FULLER & THALER ASSET MANAGEMENT, INC. | $21 646 913 | 2 116 023 | 1,26% | Akcje |
| JANE STREET GROUP, LLC | $21 222 105 | 2 074 497 | 1,23% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $20 588 591 | 2 012 570 | 1,19% | Akcje |
| AMERIPRISE FINANCIAL INC | $19 667 133 | 1 922 496 | 1,14% | Akcje |
| Nuveen, LLC | $19 330 046 | 1 889 545 | 1,12% | Akcje |
| CITADEL ADVISORS LLC | $18 466 225 | 1 805 105 | 1,07% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $17 166 963 | 1 678 100 | 1,00% | Akcje |
| JENNISON ASSOCIATES LLC | $15 300 726 | 1 495 672 | 0,89% | Akcje |
| Woodline Partners LP | $14 577 873 | 1 425 012 | 0,85% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $12 303 908 | 1 202 728 | 0,71% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11 951 167 | 1 168 247 | 0,69% | Akcje |
| MACKENZIE FINANCIAL CORP | $11 718 127 | 1 145 467 | 0,68% | Akcje |
| Black Creek Investment Management Inc. | $11 049 812 | 1 080 138 | 0,64% | Akcje |
| MORGAN STANLEY | $10 919 254 | 1 067 375 | 0,63% | Akcje |
| NORTHERN TRUST CORP | $10 630 587 | 1 039 158 | 0,62% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $10 428 431 | 1 019 397 | 0,61% | Akcje |
| JPMORGAN CHASE & CO | $10 119 531 | 909 482 | 0,59% | Akcje |
| Balyasny Asset Management L.P. | $9 858 150 | 963 651 | 0,57% | Akcje |
| Qube Research & Technologies Ltd | $9 400 899 | 918 954 | 0,55% | Akcje |
| FIRST TRUST ADVISORS LP | $7 709 859 | 753 652 | 0,45% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 272 507 | 710 900 | 0,42% | Opcja kupna |
| Applied Fundamental Research, LLC | $7 132 837 | 697 247 | 0,41% | Akcje |
| FMR LLC | $6 806 788 | 665 375 | 0,39% | Akcje |
| TWO SIGMA ADVISERS, LP | $6 297 984 | 554 400 | 0,37% | Akcje |
| UBS Group AG | $6 263 532 | 612 271 | 0,36% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $5 980 192 | 584 574 | 0,35% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $5 862 680 | 573 087 | 0,34% | Akcje |
| Hillsdale Investment Management Inc. | $5 134 539 | 501 910 | 0,30% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4 831 915 | 472 328 | 0,28% | Akcje |
| RICE HALL JAMES & ASSOCIATES, LLC | $4 204 653 | 411 012 | 0,24% | Akcje |
| D. E. Shaw & Co., Inc. | $4 196 581 | 410 223 | 0,24% | Akcje |
| BANK OF AMERICA CORP /DE/ | $3 877 977 | 379 079 | 0,23% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $3 614 597 | 353 333 | 0,21% | Akcje |
| Malaga Cove Capital, LLC | $3 492 164 | 341 365 | 0,20% | Akcje |
| ALGERT GLOBAL LLC | $3 484 573 | 340 623 | 0,20% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3 360 892 | 328 533 | 0,20% | Akcje |
Aktywiści i właściciele 5%+ 6 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Hasson Heather L. ×3 zgłoszenia | 12 maja 2026 | 8,40% | Aneks | · | SEC |
| Spear Catherine Eva ×3 zgłoszenia | 12 maja 2026 | 15,00% | Aneks | · | SEC |
| BAMCO INC /NY/, Baron Capital Management, Inc, Ronald Baron, Baron Capital Group, Inc, Baron Growth Fund, Baron Focused Growth Fund ×7 zgłoszenia | 3 marca 2026 | 37,93% | Aneks | · | SEC |
| Thomas J. Tull ×5 zgłoszenia | 21 lutego 2025 | 0,00% | Aneks | · | SEC |
| Catherine Spear ×8 zgłoszenia | 28 sierpnia 2024 | · | Pierwotne zgłoszenie | · | SEC |
| Heather Hasson ×8 zgłoszenia | 28 sierpnia 2024 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 18 insiderów · 5 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Catherine Eva Spear | Chief Executive Officer | 1 lipca 2026 F | 1 733 408 | 0 | 3 | $-1 894 115 |
| Sarah Oughtred | Chief Financial Officer | 5 sierpnia 2026 F | 1 088 165 | 0 | 6 | $-1 097 115 |
| Kevin Fosty | Former Interim CFO | 7 sierpnia 2024 S | 65 536 | 0 | 0 | $0 |
| Daniella Turenshine | Chief Financial Officer | 5 marca 2024 S | 409 858 | 0 | 0 | $0 |
| Hasson Heather L. | Executive Chairman | 5 sierpnia 2026 F | 1 396 852 | 0 | 4 | $-10 252 337 |
| Hsiao Yueh Jao | Dyrektor | 3 czerwca 2026 A | 97 719 | 0 | 0 | $0 |
| Kenneth Jian-Hong Lin | Dyrektor | 3 czerwca 2026 A | 161 705 | 0 | 0 | $0 |
| John Martin Willhite | Dyrektor | 3 czerwca 2026 A | 3 263 095 | 0 | 0 | $0 |
| Sheila Antrum | Dyrektor | 3 czerwca 2026 A | 115 663 | 0 | 0 | $0 |
| Melanie Anya Whelan | Dyrektor | 3 czerwca 2026 A | 55 683 | 0 | 0 | $0 |
| Mario Jesus Marte | Dyrektor | 3 czerwca 2026 A | 86 046 | 0 | 0 | $0 |
| Jeffrey A Wilke | Dyrektor | 3 czerwca 2026 A | 227 577 | 0 | 0 | $0 |
| Alan G Lafley | Dyrektor | 17 grudnia 2024 G | 141 165 | 0 | 0 | $0 |
| Michael J Soenen | Dyrektor | 7 czerwca 2023 A | 52 652 | 0 | 0 | $0 |
| Christopher Peter Varelas | Dyrektor | 1 czerwca 2021 P | 52 274 | 0 | 0 | $0 |
| BAMCO INC /NY/ | Posiadacz 10% | 20 lutego 2025 C | 27 833 825 | 0 | 0 | $0 |
| Thomas J. Tull | Posiadacz 10% | 11 stycznia 2025 X | 6 675 631 | 0 | 0 | $0 |
| Tulco, LLC | Posiadacz 10% | 21 marca 2022 C | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 36 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PEZ · Invesco Exchange-Traded Fund Trust | 3,05% | 46 890 SH | 2 października 2026 | Dziennie |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,28% | 343 129 NS | 31 lipca 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 234 929 SH | 19 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 15 299 SH | 2 października 2026 | Dziennie |
| IWO · iShares Trust | 0,08% | 893 638 SH | 11 września 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 85 273 NS | 31 lipca 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 102 017 SH | 19 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 31 082 NS | 31 lipca 2026 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0,06% | 88 497 NS | 31 lipca 2026 | N-PORT |
| VCR · VANGUARD WORLD FUND | 0,05% | 355 298 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 80 276 SH | 2 października 2026 | Dziennie |
| EBIT · Harbor ETF Trust | 0,04% | 471 NS | 31 lipca 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 2 429 839 SH | 11 września 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,04% | 521 429 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 26 052 SH | 11 września 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 22 416 NS | 31 lipca 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 45 466 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 547 697 SH | 19 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1 821 842 SH | 19 sierpnia 2026 | Dziennie |
| VBK · VANGUARD INDEX FUNDS | 0,02% | 1 148 655 SH | 19 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 5 743 SH | 11 września 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,01% | 1 997 017 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,01% | 390 844 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 17 756 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 11 938 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 8 908 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 59 278 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 36 685 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 223 355 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 34 315 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23 946 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,00% | 88 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 758 703 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 241 SH | 19 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 3 675 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 35 184 SH | 11 września 2026 | Dziennie |
FIGS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
8 analityków · 2026-09-29Średnia cel $18.62 +37,8%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| FIGS | · | 59.8 | 13.6% | 5.4% | 8.2% | 66.5% |
| LEVI | $8.60B | 15.2 | 4.1% | 9.2% | 26.5% | 61.7% |
| VFC | $6.42B | 25.6 | 1.1% | 2.6% | 15.3% | · |
| PVH | · | 119.9 | 3.4% | 0.28% | 0.52% | 57.5% |
| KTB | $3.40B | 15.2 | 20.9% | 7.2% | 42.8% | · |
| COLM | · | 17.0 | 0.85% | 5.2% | 10.5% | 50.5% |
| UAA | · | -5.1 | -3.8% | -10.0% | -30.3% | 45.5% |
| GIII | · | 19.0 | -7.0% | 2.3% | 3.9% | 39.4% |
| CRI | $1.21B | 13.1 | 1.9% | 3.2% | 10.3% | 45.4% |
| MOV | · | 19.5 | 2.7% | 4.0% | 5.4% | 54.2% |
| FOSL | · | -2.6 | -12.3% | · | · | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.